Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input.
about
Rizatriptan reduces vestibular-induced motion sickness in migraineurs.Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implicationsMigraine pathophysiology.Can we develop neurally acting drugs for the treatment of migraine?New migraine and pain research.Distribution of 5-HT1F Receptors in Monkey Vestibular and Trigeminal Ganglion Cells.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.An update on migraine: current understanding and future directions.Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.Pathophysiology of Migraine: A Disorder of Sensory Processing.Episodic dural stimulation in awake rats: a model for recurrent headache.Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptanBench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients.Migraine Therapy: Current Approaches and New Horizons.Targeted 5-HT1F Therapies for Migraine.Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
P2860
Q34771010-725390B9-DFA4-4F6D-9BE6-49C1612B4D2DQ35023333-B5D4A254-91C7-40D4-BAF2-B69B684A4325Q36099504-60F8B531-E5A8-4772-BF89-C5AE7E472EE1Q36240187-4B52865C-F880-4576-A131-64479FCDF767Q36787453-09A3D4EA-B9D2-4356-AE13-ADACCD9667B3Q37323725-4D73A947-D88F-4EAE-ABBB-CEAE26984CD8Q38129436-DE4B2654-9F73-41F4-A54B-337B9180F439Q38742593-E4285D2C-8F23-4E35-A642-F83F2F99104DQ38961181-B0902A8B-986D-4317-A19E-85F2485BE01CQ39127073-7FBC85A3-31A8-4273-9A9F-2859817EB654Q39834643-6ADE4E84-FC33-4A85-86E2-BFC8B93C65C8Q40532425-85156145-ABF6-41B1-B36D-2D4656923E1BQ48495487-4B6F1DB7-F14E-44F0-9599-B63DB6FAC9D9Q52581504-BFEDF6CC-8127-4CFA-817E-E91D079A109AQ52682101-3564EE9B-5AC8-4867-8503-C89165F4BAD7Q57481750-8856640E-7A70-4BD4-AB45-3AFDB83FA963
P2860
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@ast
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@en
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@nl
type
label
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@ast
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@en
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@nl
prefLabel
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@ast
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@en
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@nl
P1433
P1476
Evidence for serotonin (5-HT)1 ...... ons with craniovascular input.
@en
P2093
Classey JD
Goadsby PJ
P304
P356
10.1016/S0306-4522(03)00570-0
P407
P577
2003-01-01T00:00:00Z